UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The New England journal of medicine, ISSN 0028-4793, 07/2016, Volume 375, Issue 2, pp. 134 - 142
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Aprepitant | Olanzapine | Double-Blind Method | Nausea - chemically induced | Humans | Middle Aged | Male | Nausea - prevention & control | Vomiting - chemically induced | Dexamethasone - therapeutic use | Antineoplastic Agents - adverse effects | Antiemetics - therapeutic use | Intention to Treat Analysis | Aged, 80 and over | Adult | Antiemetics - adverse effects | Female | Aged | Benzodiazepines - adverse effects | Drug Therapy, Combination | Benzodiazepines - therapeutic use | Vomiting - prevention & control | Morpholines - therapeutic use | Complications and side effects | Care and treatment | Chemotherapy | Vomiting | Dosage and administration | Nausea | Cancer | Heart attacks | Dexamethasone | Serotonin | Nervous system | Doxorubicin | Cisplatin | Studies | Psychotropic drugs | Cyclophosphamide | Diabetes | Drug therapy | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 03/2016, Volume 374, Issue 10, pp. 928 - 939
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Humans | Sulfadoxine - adverse effects | Quinolines - administration & dosage | Incidence | Young Adult | Malaria - epidemiology | Sulfadoxine - therapeutic use | Adult | Female | Parasitemia - epidemiology | Drug Resistance | Pyrimethamine - therapeutic use | Antimalarials - adverse effects | Double-Blind Method | Drug Administration Schedule | Pyrimethamine - adverse effects | Artemisinins - administration & dosage | Antimalarials - therapeutic use | Malaria - prevention & control | Pregnancy | Vomiting - chemically induced | Adolescent | Pregnancy Complications, Parasitic - prevention & control | Uganda | Artemisinins - adverse effects | Drug Combinations | Pregnancy Outcome | Quinolines - adverse effects | Care and treatment | Usage | Malaria | Pregnant women | Pyrimethamine | Clinical trials | Dosage and administration | Health aspects | Dihydroartemisinin | Preventive medicine | Studies | Placenta | Womens health | Vomiting | Human immunodeficiency virus--HIV | Sulfadoxine | Parasitemia | Drug therapy | Adolescents | Index Medicus | Abridged Index Medicus
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 04/2011, Volume 29, Issue 11, pp. 1495 - 1501
Life Sciences & Biomedicine | Oncology | Science & Technology | Biological and medical sciences | Medical sciences | Tumors | Dexamethasone - administration & dosage | Double-Blind Method | Drug Administration Schedule | Nausea - chemically induced | Humans | Middle Aged | Morpholines - administration & dosage | Antiemetics - administration & dosage | Ondansetron - administration & dosage | Male | Treatment Outcome | Nausea - prevention & control | Vomiting - chemically induced | Dexamethasone - therapeutic use | Antineoplastic Agents - adverse effects | Ondansetron - therapeutic use | Antiemetics - therapeutic use | Aged, 80 and over | Cisplatin - adverse effects | Adult | Female | Aged | Vomiting - prevention & control | Morpholines - therapeutic use | Index Medicus
Journal Article
American family physician, ISSN 0002-838X, 2017, Volume 95, Issue 7, pp. 442 - 449B
Internal Medicine | Medicine, General & Internal | Primary Health Care | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Pregnancy | Oxytocin - administration & dosage | Guidelines as Topic | Postpartum Hemorrhage - prevention & control | Postpartum Hemorrhage - therapy | Postpartum Hemorrhage - diagnosis | Humans | Oxytocics - administration & dosage | Female | Treatment Outcome | Postpartum Hemorrhage - etiology | Blood Transfusion - methods | Prevention | Treatment outcome | Care and treatment | Oxytocin | Analysis | Dosage and administration | Diagnosis | Health aspects | Uterine bleeding | Childbirth | Episiotomy | Postpartum period | Physicians | Anemia | Fetuses | Nausea | FDA approval | Blood banks | Hemorrhage | Obstetrics | Risk factors | Hypotension | Childbirth & labor | Disease prevention | Maternal mortality | Placenta | Uterus | Ischemia | Womens health | Vomiting | Hemoglobin | Patient safety | Index Medicus | Abridged Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 05/2018, Volume 319, Issue 19, pp. 1985 - 1987
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Calcitonin Gene-Related Peptide | Migraine Disorders | Antibodies, Monoclonal | Disease prevention | Prevention | Headache | Vomiting | Migraine | Neurological complications | Monoclonal antibodies | Nausea
Journal Article
Critical reviews in oncology/hematology, ISSN 1040-8428, 08/2020, Volume 152, pp. 103012 - 103012
NK1 inhibitors | Systematic review | Dexamethasone | Corticosteroids | Chemotherapy-induced nausea and vomiting | Meta-analysis | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Prevention | Complications and side effects | Medical research | Chemotherapy | Analysis | Medicine, Experimental | Nausea | Cancer | Index Medicus
Journal Article
Supportive care in cancer, ISSN 0941-4355, 5/2017, Volume 25, Issue 5, pp. 1661 - 1671
Chemotherapy-induced nausea and vomiting (CINV) | Pain Medicine | Nursing | Rehabilitation Medicine | Medicine & Public Health | Nursing Research | NK 1 receptor antagonist | Chemotherapy-induced nausea (CIN) | Oncology | Antiemetic guidelines | receptor antagonist | Health Care Sciences & Services | Rehabilitation | Life Sciences & Biomedicine | Science & Technology | Vomiting - chemically induced | Nausea - chemically induced | Antineoplastic Agents - adverse effects | Antiemetics - therapeutic use | Humans | Neurokinin-1 Receptor Antagonists - therapeutic use | Quality of Life - psychology | Prevention | Medical colleges | Chemotherapy | Dexamethasone | Nausea | Patient compliance | Cancer | Side effects | Antagonist drugs | Clinical outcomes | Meta-analysis | Index Medicus | Review | NK1 receptor antagonist
Journal Article
The New England journal of medicine, ISSN 0028-4793, 02/2017, Volume 376, Issue 5, pp. 429 - 439
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | P-Selectin - antagonists & inhibitors | Double-Blind Method | Pain - prevention & control | Anemia, Sickle Cell - complications | Antibodies, Monoclonal - pharmacology | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Anemia, Sickle Cell - drug therapy | Young Adult | Adolescent | Pain - etiology | Quality of Life | Adult | Female | Hydroxyurea - therapeutic use | Drug Therapy, Combination | P-Selectin - immunology | Viral antibodies | Prevention | Usage | Care and treatment | Safety and security measures | Sickle cell anemia | Antibodies | Dosage and administration | Patients | Occlusion | Spleen | Chest | Arthralgia | Body weight | Neutrophils | Diarrhea | Hydroxyurea | Inflammation | Pruritus | Cell interactions | Endothelial cells | Endothelium | Pain | Blood platelets | Vomiting | Transgenic animals | Hemoglobin | Sickle cell disease | P-selectin | Index Medicus | Abridged Index Medicus
Journal Article
Annals of oncology, ISSN 0923-7534, 05/2010, Volume 21, Issue 5, pp. v232 - v243
Journal Article
Drug safety, ISSN 0114-5916, 04/2017, Volume 40, Issue 4, pp. 273 - 283
HIV Infections | Tenofovir | Animals | Humans | Anti-HIV Agents | Review | Journal Article | Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination | Pre-Exposure Prophylaxis | Medicine & Public Health | Drug Safety and Pharmacovigilance | Pharmacology/Toxicology | Pharmacology & Pharmacy | Public, Environmental & Occupational Health | Toxicology | Life Sciences & Biomedicine | Science & Technology | Anti-HIV Agents - administration & dosage | HIV Infections - prevention & control | Pre-Exposure Prophylaxis - methods | Tenofovir - adverse effects | Anti-HIV Agents - adverse effects | Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination - administration & dosage | Tenofovir - administration & dosage | Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination - adverse effects | Prevention | Clinical trials | Usage | Drug therapy | HIV infection | Intervention | Renal function | Toxicity | Liver | Prophylaxis | Viruses | Infections | Incidence | Mens health | Hepatitis | Acquired immune deficiency syndrome--AIDS | Vomiting | Human immunodeficiency virus--HIV | Risk assessment | Search engines | Bone density | Safety | Product safety | Drug dosages | Drug use | Monitoring | Emtricitabine | Enzymes | Medical research | Effectiveness | Health risks | Diarrhea | Exposure | Nausea | Pharmacology | Disease control | Disease prevention | Side effects | Disease transmission | Reviews | Bone mineral density | Kidney transplantation | Index Medicus
Journal Article